1 / 24

Overview

EU – Russia Symposium on S&T Co-operation in Biotechnology Moscow, 14 – 15 March 2005 EU Strategies for Life Sciences and Biotechnology Research Dr. Christian Patermann European Commission DG Research. Overview.

yael-emerson
Download Presentation

Overview

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript

  1. EU – Russia Symposium onS&T Co-operation in BiotechnologyMoscow, 14 – 15 March 2005EU Strategies for Life Sciences and Biotechnology ResearchDr. Christian PatermannEuropean CommissionDG Research

  2. Overview - EU Research, - Life Sciences and Biotechnology Strategy - Developments towards FP7 (2006-2013)

  3. The strategic objective set at Lisbon in March 2000 for the following decade, by the heads of government of the European Union, to become: the most competitive and dynamic knowledge-based economy in the world capable of sustainable economic growth with more and better jobs and greater social cohesion. TheLisbon objective

  4. Life Sciences and Biotechnology-A Strategy and Action Plan for EuropeCOM(2002)27 -23 January 2002

  5. Life Science and Biotechnology A Strategy for Europe Lisbon Summit - March 2000 Sets a strategic goal for Europe to become the most competitive and dynamic knowledge-based economy in the world Stockholm Summit - March 2001 Highlights the importance of research,entrepreneurship... Identifies biotechnology as a frontier technology … and requests the Commission, together with the Council, to examine measures required to utilise the full potential of biotechnology and strengthen the European biotechnology sector's competitiveness THE POLITICAL DRIVE

  6. Life Science and Biotechnology A Strategy for Europe How can Europe best attract the human, industrial and financial resources to develop and apply these technologies to meet society’s needs and increase its competitiveness? How can Europe deliver effective, credible and responsible policies, which deliver the confidence and support of its citizens? How can Europe best respond to the global challenges, develop its domestic policies with a clear international perspective and act internationally to pursue its interests? KEY QUESTIONS

  7. Life Science and Biotechnology A Strategy for Europe 2 1 GOVERNING Life Sciences and Biotechnology HARVESTING the POTENTIAL 4 3 Implementation and COHERENCE across policies, sectors and actors RESPONDING to GLOBAL challenges ACTION PLAN EC + EP + COUNCIL + MEMBER STATES + REGIONS + PRIVATE SECTOR + ACADEMIA + PROFESSIONAL ASSOCIATIONS + CIVIL SOCIETY + EIB + EFSA + EMEA + EGE ... Who? How?

  8. Life Science and Biotechnology Action Plan EUROPE in THE WORLD: RESPONDING to GLOBAL CHALLENGES • A European agenda for international collaboration • Europe’s responsibilities towards the developing world

  9. SUCCESS will depend on MOBILISATION OF ALL ACTORS Ethical Bodies Academia Private Sector Regions RESEARCH DEVELOPMENT REGULATION European Investment Bank Civil Society Parliament Member States Commission DELIVERABLES FOR SOCIETY

  10. 'returning to growth will require considerable investment in knowledge. [...] Only well trained people can ensure high productivity. This requires an unprecedented effort on research, innovation, education and training. A particular effort will be required to involve young people in this investment for knowledge.' 12/01/2005 “Research and Innovation must be central to the Lisbon Strategy” José Manuel Barroso President of the European Commission

  11. Developments towards FP7(2006-2010)

  12. ‘Let’s focus on what is our main, if not only, comparative advantage : knowledge … Our competitiveness, the basis for economic growth and employment, depends on how good we are at making the knowledge triangle (education – research – innovation) produce economic value by integrating it in favourable framework conditions which mostly require action at the EU level’ 10/12/2004 “I propose to concentrate onKnowledge for Growth”Janez PotočnikEuropean Commissioner for Research

  13. Financial Perspectives 2007 – 2013 (Feb). Proposed doubling of EU research budget Role of EU research support: complement, reinforce, and strengthen the impact of national actions (collaboration; the diffusion of knowledge; the creation of “critical masses” of financial and human resources etc.) FP6 introduced range of initiatives to enhance this value added and provide more structured support. Now necessary to go a step further… Developments towards FP7 (2006-2010)

  14. Commission’s Communication on Future Research Policy (16 June) to launch political debate ahead of Proposals for FP7 (early 2005) (http://europa.eu.int/comm/research/future/index_en.html) 6 major objectives to increase the impact of EU’s actions 2 new fields of research: space and security Future Orientations

  15. Six Major Objectives Technology initiatives Excellence throughcollaboration Basic researchthroughcompetition Humanresources Coordination of national programmes Researchinfrastructures new new 6 axes

  16. The new knowledge and techniques will be central in enabling us to: - switch to a more sustainable agriculture; reduce and reverse environmental degradation; strengthen the competitiveness of our economy; increase agricultural productivity; improve the quality of health care; hence meet the needs of a 50% increase of population; without expanding the farmed area. To achieve this will require a public policy context, at all levels – regional, national, European, OECD, global – which is rationally conceived, to stimulate and welcome innovation. The challenge

  17. THE EUROPEAN KNOWLEDGE-BASED BIOECONOMY QUALITY ASSURANCE STRATEGIES TRACEABILITY, CONSUMER SCIENCE SOCIETAL NEEDS STABILITY - BIODEGRADABILITY FUNCTIONALITY (Chirality) Life sciences & biotechnology for sustainable non-food products + processes “Fork to Farm”Food, health and well-being WHITEBIOTECH CLEAN BIOPROCESSES RAW MATERIALS/WASTE ADVANCED FOOD TECHNOLOGIES, FOOD QUALITY DETERMINANTS, NUTRITION PROCESSING GREEN/BLUE BIOTECH OPTIMISED RAW MATERIALS LOW INPUT FARMING - BIODIVERSITY ANIMAL HEALTH - RURAL DEVT. PRODUCTION Sustainable production and management of biological resources from land, forest, and aquatic environments

  18. The KBBE reacts to: Growing European and global demand for secure, healthy and sufficient food, produced according to ethically acceptable environmental standards and observing animal protection issues Growing demand to utilise renewable biological instead of fossil resources for energy production and production of industrial goods EU enlargement (doubling of employees in agriculture) Growing risk of food-related diseases etc. The Knowledge-Based Bio-Economy (KBBE)

  19. Innovation and knowledge generation in sustainable management of biological resources (micro-organisms, plants, animals) form the basis for: - new, sustainable, eco-efficient and innovative products for agriculture, food, health and related industrial sectors  Green and red biotechnology, and for biomaterials and “clean” production processes  White biotechnology The Knowledge-Based Bio-Economy (KBBE)

  20. CONSUMER ACCEPTANCE / INDUSTRY VERTICAL PILLAR 2 Fork to farm: Food, health and well-being VERTICAL PILLAR 3 Life sciences and biotechnology for sustainable non-food products and processes PROCESSING TECHNOLOGIES SUPPORT TO POLICIES BASICS / « OMICS » COMMON ACTIONS (INCO, TRAINING, GENDER,ETHICS, ETC) HORIZONTAL PILLAR 1 : SUSTAINABLE BIOLOGICAL RESOURCES EUROPEAN KNOWLEDGE – BASED BIO ECONOMY

  21. Three possible pillars: Sustainable production and management of biological resources from land, forest, aquatic environments Fork to farm: Food, health and well-being Life sciences and biotechnology for sustainable non-food products and processes Future bio-agri-food research in FP7?

  22. Fossil resources ----------------> Product short-term Bio-catalysis Biomass -------------------------> Product medium-term Bio-catalysis Optimised ------------------------ > Product long-term Biomass The Future

  23. Future health research in FP7? Three possible areas: • Biotechnology: Generic tools and technologies for human health(high-throughput research, detection – diagnosis – monitoring, predicting suitability – safety – efficacy of therapies, innovative therapeutic approaches and intervention) • Translating research for human health(integrating biological data and processes - large-scale data gathering - systems biology, brain and related diseases, human development and ageing, translational research into: infectious diseases, cancer, CVD, diabetes / obesity, rare diseases, other chronic diseases) • Optimising the delivery of health care to European citizens(translating clinical outcome into clinical practice, quality – efficiency – solidarity of health systems, analysing changes in population, enhanced disease prevention and better use of medicines)

  24. 2005 Apr Adoption of FP7 proposal by EC Sep EC proposals on Specific Programmes (SP) and Rules for participation (RfP) Nov EP – First reading on FP 2006 Jan Council – Common position on FP and RfP Mar EP – Second reading on FP and RfP Apr EP – Opinion on SP Jun Council + EP – Adoption of FP and RfP Jul Council – Adoption of SP Oct EC – Adoption of WPGs and model contracts Nov EC – Publication of first calls Tentative Timetable

More Related